Cme Group Inc. (CME) Stock Price & Analysis
Cme Group Inc. (CME) rose 1.55% to USD 255.94 as of June 9, 2026 at 22:34 UTC, according to Nexqual real-time market data.
CME last closed at USD 252.03; the session ranged USD 250.48–260.49 on volume of 3,483,776 shares. Market capitalization is $92.48B, with a 52-week range of USD 244.56–329.16 (NMS). Source: Nexqual, June 9, 2026 at 22:34 UTC.
Key Statistics (as of June 9, 2026 at 22:34 UTC)
| Price | USD 255.94 |
|---|---|
| Change | ▲ 1.55% (up) |
| Previous Close | USD 252.03 |
| Open | USD 252 |
| Day Range | USD 250.48 – 260.49 |
| 52-Week Range | USD 244.56 – 329.16 |
| Volume | 3,483,776 shares |
| Market Cap | $92.48B |
| Exchange | NMS |
Technical Analysis (CME)
Nexqual's technical model rates CME "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 22:34 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.28 (neutral) |
| vs SMA50 | Below (USD 286.35) |
| MACD | -10.31 (negative) |
Analyst Ratings (CME)
Wall Street analysts rate CME "Hold" based on 15 analysts, with a mean price target of USD 305.47 (range USD 230–353), per Nexqual as of June 9, 2026 at 22:34 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 305.47 |
| High Target | USD 353 |
| Low Target | USD 230 |
| Buy / Hold / Sell | 7 / 6 / 3 |
Earnings (CME)
| Next Earnings Date | 2026-07-22 |
|---|---|
| EPS Estimate | USD 2.98 |
| Revenue Estimate | $1.73B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 3.36 vs est 3.37 ▼ miss |
| 2025-12-31 | USD 2.77 vs est 2.74 ▲ beat |
| 2025-09-30 | USD 2.68 vs est 2.63 ▲ beat |
| 2025-06-30 | USD 2.96 vs est 2.92 ▲ beat |
Source: Nexqual, June 9, 2026 at 22:34 UTC.
Financials & Fundamentals (CME)
| Total Revenue | $6.74B |
|---|---|
| Revenue Growth (YoY) | +14.40% |
| Gross Margin | +100.00% |
| Operating Margin | +69.81% |
| Profit Margin | +63.32% |
| ROE | +15.92% |
| Debt / Equity | 14.06 |
| Current Ratio | 1.02 |
| Total Cash | $2.52B |
| Total Debt | $3.74B |
| Free Cash Flow | $3.03B |
Source: Nexqual, June 9, 2026 at 22:34 UTC.
Financial Health Score (CME)
Nexqual rates Cme Group Inc.'s overall financial health "Strong" across five dimensions, as of June 9, 2026 at 22:34 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Operating margin 70% |
| Balance Sheet | Strong — $2.52B cash vs $3.74B debt |
| Cash Flow | Strong — FCF $3.03B, 46% margin |
| Efficiency | Solid — ROE 16%, ROA 1.6% |
Ownership (CME)
| Insider Ownership | +0.41% |
|---|---|
| Institutional Ownership | +92.59% |
| Shares Outstanding | 361.32M |
| Float | 357.28M |
| Short % of Float | +1.47% |
Source: Nexqual, June 9, 2026 at 22:34 UTC.
Leadership (CME)
Cme Group Inc. is led by Terrence A. Duffy (age 67), Chairman & CEO, per Nexqual as of June 9, 2026 at 22:34 UTC.
| Chairman & CEO | Terrence A. Duffy (age 67) |
|---|---|
| President & CFO | Lynne Fitzpatrick (age 46) |
| Senior MD, Group COO & Global Head of Clearing | Suzanne Sprague |
| Senior Managing Director of Corporate Marketing & Communications | Anita Liskey (age 60) |
Major Backers & Investors (CME)
Notable institutional backers of Cme Group Inc. include JPMorgan, Morgan Stanley, Capital Group, according to Nexqual as of June 9, 2026 at 22:34 UTC.
Active Investors
| Investor | Stake |
|---|---|
| JPMorgan | 3.37% |
| Morgan Stanley | 2.6% |
| Capital Group | 1.91% |
| Price (T.Rowe) Associates Inc | 1.33% |
| Fidelity | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 15.53% |
| BlackRock | 9.97% |
| State Street | 5.62% |
| Geode Capital | 2.52% |
| BNY Mellon | 1.33% |
Source: Nexqual, June 9, 2026 at 22:34 UTC.
From Cme Group Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- This includes, but is not limited to, the successful development and migration of our markets and supporting operational and business functions to the Google Cloud in the new private Google Cloud region.
- We attempt to protect our proprietary technology and intellectual property rights by relying on patents, trademarks, copyright, database rights, trade secrets, restrictions on disclosure, and other methods.
- Notwithstanding the precautions we take to protect our proprietary technology and intellectual property rights, it is possible that employees or third parties may copy, misappropriate, or otherwise obtain and use our proprietary technology without authorization or otherwise infringe on our rights.
- Our business is dependent on proprietary technology and intellectual property that we own or license from third parties.
Partnerships
- We may issue additional equity and/or debt as part of strategic partnerships with third parties, as was the case in connection with our partnership with Google Cloud.
- Our usage of mobile, web, and cloud technologies, such as those pursuant to our partnership with Google Cloud, may increase our risk of a cyber attack.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ICE | Intercontinental Exchange Inc. | USD 141.56 | ▲ 0.04% |
| CBOE | Cboe Global Markets, Inc. | USD 290.6 | ▲ 3.08% |
| NDAQ | Nasdaq, Inc. | USD 87.52 | ▲ 0.27% |
| SPGI | S&P Global Inc. | USD 424.82 | ▲ 0.09% |
| MCO | Moody's Corporation | USD 449.94 | ▼ 0.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 22:34 UTC. This page is informational and not investment advice.